Educational guide
A tumor-penetrating peptide iRGD by LifeTein targets peritoneal carinomatosis | LifeTein Peptide Blog
A tumor-penetrating peptide, iRGD, was synthesized by LifeTein. It was found that iRGD improves tumor-specific penetration of intraperitoneal compounds and enhances intraperitoneal chemotherapy (IPC) in mice. This penetration was tumor-specific. When the FITC
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
A tumor-penetrating peptide, iRGD, was synthesized by LifeTein. It was found that iRGD improves tumor-specific penetration of intraperitoneal compounds and enhances intraperitoneal chemotherapy (IPC) in mice. This penetration was tumor-specific. When the FITC was attached to iRGD and mixed with nanoparticles, the mixture could penetrate into fresh human peritoneal metastasis explants. The evidence proved that the LifeTein iRGD enhanced intratumoral entry. The intraperitoneal iRGD co-administration is a simple and effective strategy to facilitate tumor detection and potential application for therapeutic improvement.
LifeTein’s Peptide: iRGD
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis, Journal of Controlled Release, Volume 212, 28 August 2015, Pages 59–69
Peptide Synthesis Home Page
Our Services:
COVID-19 Services & Products
Custom Antibody Services
Rush Peptide Synthesis
Peptide Nucleic Acids (PNAs)
Custom Peptide Synthesis Services
Gene Synthesis Service
Custom Chemical Synthesis
Other Posts:
Nanoparticles Get Help from Cell-Permeable Peptides
Predicting type 1 diabetes in children
Improving Antibody Therapy For Colorectal Cancer
To Make Simpler and Better Biosensors
A New Patent Using Peptides